Biotechnology
Technology
Health

Kadmon

1,015

$3.99
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.07 (-1.72%) Today
$0.00 (0.00%) As of 6:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Kadmon and other stocks, options, ETFs, and crypto commission-free!

About KDMN

Kadmon Holdings, Inc., also called Kadmon, is a biopharmaceutical company, which engages in discovering, developing, and commercializing small molecules and biologics. It focuses on the treatment of autoimmune, inflammatory, and fibrotic diseases. Read More Its products include Ribasphere, RibaPak, Tetrabenazine, Valganciclovir, Abacavir, Entecavir, Lamivudine, and Zidovudine. The company was founded by Steven N. Gordon in September 2010 and is headquartered in New York, NY.

CEO
Harlan W. Waksal
Employees
115
Headquarters
New York, New York
Founded
2010
Market Cap
621.48M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.82M
High Today
$4.10
Low Today
$3.75
Open Price
$3.87
Volume
2.58M
52 Week High
$5.50
52 Week Low
$1.63

Collections

Biotechnology
Technology
Health
Biopharmaceutical
Pharmaceutical
2016 IPO
US
North America

KDMN Earnings

-$0.49
-$0.30
-$0.12
$0.07
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 7, After Hours

People Also Bought

Viking Therapeutics

49,748

$4.75

-1.86%

Viking Therapeutics

49,748

$4.75

-1.86%

Amarin

17,314

$13.08

-4.53%

Agile Therapeutics

20,012

$1.90

-5.47%

Inovio

208,169

$8.72

+21.96%

You May Also Like

KODK
VLUE
SMP
GBCI
NOVN
XSPA
IGV
DPST
TDW+A
POPE
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy KDMN

Market Price$3.99
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell Kadmon stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up